Agreement - February 13, 2014
Enzymatica starts sale of ColdZyme at airports
The company has signed an agreement with pharmaceutical wholesaler Pharmaxim to distribute ColdZyme at Swedish airports. Air-passengers are an important target group for Enzymatica’s cold treatment spray, claims the company, refering to a US study which has shown that one in five passengers catch a cold after a flight. The company further states that ColdZyme Mouth […]
New Market - November 7, 2013
Enzymatica sets up a subsidiary in the USA
The biotech company, Enzymatica, is to offer a new product line, veterinary products, and is planning for sales in the North American market. The first products will be launched in mid-2014, and are expected to generate sales for Enzymatica during the second half of the year. Over the past few years, Enzymatica has devoted considerable […]
Acquisition - June 7, 2013
Enzymatica signs agreement with Actavis
Enzymatica and the international pharmaceuticals company, Actavis, have signed a letter of intent on the sale of Enzymatica’s cold treatment product, ColdZyme Mouth Spray, on the Nordic market. Under the agreement, the product will be on sale in around 3,200 pharmacies and a large number of stores, including health food retailers, in the Nordic region. Actavis […]
